Eiger BioPharmaceuticals announces pricing of public offering of common stock
Eiger BioPharmaceuticals announced pricing of an underwritten public offering of 4,500,000 shares of its common stock at a price to the public of $11.00 per share. Eiger granted underwriters a 30-day option to purchase up to an additional 675,000 shares of its common stock. April 18, 2019